HCA HEALTHCARE INC (HCA) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:HCA • US40412C1018
503.405 USD
+4.19 (+0.84%)
Last: Feb 4, 2026, 11:42 AM
ChartMill assigns a Buy % Consensus number of 75% to HCA. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 537.27. This target is 6.73% above the current price.
- HCA was analyzed by 31 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about HCA.
- In the previous month the buy percentage consensus was at a similar level.
- HCA was analyzed by 31 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-30 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-28 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-28 | UBS | Maintains | Buy -> Buy |
| 2026-01-28 | Deutsche Bank | Maintains | Buy -> Buy |
| 2026-01-28 | Keybanc | Maintains | Overweight -> Overweight |
| 2026-01-28 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2026-01-28 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-28 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-28 | Truist Securities | Maintains | Buy -> Buy |
| 2026-01-28 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-07 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-15 | Morgan Stanley | Downgrade | Equal-Weight -> Underweight |
| 2025-11-13 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-28 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-27 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-27 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-27 | UBS | Maintains | Buy -> Buy |
| 2025-10-27 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-10-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-10-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-27 | Stephens & Co. | Maintains | Overweight -> Overweight |
| 2025-10-27 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-27 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-27 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-10-27 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-10-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-14 | UBS | Maintains | Buy -> Buy |
| 2025-10-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-10-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
HCA HEALTHCARE INC / HCA FAQ
What is the price target for HCA stock?
31 analysts have analysed HCA and the average price target is 537.27 USD. This implies a price increase of 6.73% is expected in the next year compared to the current price of 503.405.
What is the consensus rating for HCA HEALTHCARE INC (HCA) stock?
The consensus rating for HCA HEALTHCARE INC (HCA) is 74.8387 / 100 . This indicates that analysts generally have a positive outlook on the stock.